Management of patent ductus arteriosus in preterm infants: Clinical judgment might be a fair option

Journal of Maternal-Fetal and Neonatal Medicine

Volumn 26, Issue 18, 2013, Pages 1850-1854

  Alan, Serdar ^a   Karadeniz, Cem ^a   Okulu, Emel ^a   Kilic, Atila ^a   Erdeve, Omer ^a   Ucar, Tayfun ^a   Atasay, Begum ^a   Atalay, Semra ^a   Arsan, Saadet ^a  

^a ANKARA UNIVERSITY   (Turkey)

Author keywords

Ductus arteriosus; Echocardiographic findings; Preterm infant

Indexed keywords

IBUPROFEN;

AORTA ROOT; ARTICLE; BIRTH WEIGHT; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION ANALYSIS; ECHOCARDIOGRAPHY; FEMALE; FOLLOW UP; GESTATIONAL AGE; HEART LEFT ATRIUM; HUMAN; INFANT; MALE; MEDICAL DECISION MAKING; NEWBORN; OBSERVATIONAL STUDY; PATENT DUCTUS ARTERIOSUS; PREMATURITY; PRIORITY JOURNAL; PROSPECTIVE STUDY;

ASYMPTOMATIC DISEASES; BIRTH WEIGHT; COMORBIDITY; DECISION MAKING; DELIVERY, OBSTETRIC; DUCTUS ARTERIOSUS, PATENT; FEMALE; HUMANS; INCIDENCE; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, PREMATURE, DISEASES; MALE; PREGNANCY;

EID: 84887948712     PISSN: 14767058     EISSN: 14764954     Source Type: Journal    
DOI: 10.3109/14767058.2013.801956     Document Type: Article

References (17)

1. Mezu-Ndubuisi OJ, Agarwal G, Raghavan A, et al. Patent ductus arteriosus in premature neonates. Drugs 2012;72:907-16.
2. Hamrick SE, Hansmann G. Patent ductus arteriosus of the preterm infant. Pediatrics 2010;125:1020-30.
3. Mirea L, Sankaran K, Seshia M, et al. Treatment of patent ductus arteriosus and neonatal mortality/morbidities: adjustment for treatment selection bias. J Pediatr 2012;161:689-69.
4. Noori S. Patent ductus arteriosus in the preterm infant: to treat or not to treat? J Perinatol 2010;30:31-7.
5. Harling S, Hansen-Pupp I, Baigi A, Pesonen E. Echocardiographic prediction of patent ductus arteriosus in need of therapeutic intervention. Acta Paediatr 2011;100:231-5.
6. Sehgal A, Paul E, Menahem S. Functional echocardiography in staging for ductal disease severity. Eur J Pediatr 2013;172:179-84.
7. Knight DB. The treatment of patent ductus arteriosus in preterm infants. A review and overview of randomized trials. Semin Neonatol 2001;6:63-73.
8. Sehgal A, McNamara PJ. The ductus arteriosus: a refined approach. Semin Perinatol 2012;36:105-13.
9. Hammerman C, Bin-Nun A, Kaplan M. Managing the patent ductus arteriosus in the premature neonate: a new look at what we thought we knew. Semin Perinatol 2012;36:130-8.
10. Richardson DK, Corcoran JD, Escobar GJ, Lee SK. SNAP-II, SNAPPE-II: simplified newborn illness severity and mortality risk scores. J Pediatr 2001;138:92-100.
11. Koch J, Hensley G, Roy L, et al. Prevalence of spontaneous closure of the ductus arteriosus in neonates at a birth weight of 1000 grams or less. Pediatrics 2006;117:1113-21.
12. Erdeve O, Yurttutan S, Altug N, et al. Oral versus intravenous ibuprofen for patent ductus arteriosus closure: a randomized controlled trial in extremely low birthweight infants. Arch Dis Child Fetal Neonatal Ed 2012;97:279-83.
13. Gokmen T, Erdeve O, Altug N, et al. Efficacy and safety of oral versus intravenous ibuprofen in very low birth weight preterm infants with patent ductus arteriosus. J Pediatr 2011;158: 549-54.
14. Echtler K, Stark K, Lorenz M, et al. Platelets contribute to postnatal occlusion of the ductus arteriosus. Nat Med 2010;16:75-82.
15. Alyamac Dizdar E, Ozdemir R, Sari FN, et al. Low platelet count is associated with ductus arteriosus patency in preterm newborns. Early Hum Dev 2012;88:813-16.
16. Dani C, Poggi C, Fontanelli G. Relationship between platelet count and volume and spontaneous and pharmacological closure of ductus arteriosus in preterm infants. Am J Perinatol 2013;30:359-64.
17. Vanhaesebrouck S, Zonnenberg I, Vandervoort P, et al. Conservative treatment for patent ductus arteriosus in the preterm. Arch Dis Child Fetal Neonatal Ed 2007;92:244-7.